Novel Treatment for Rheumatoid Arthritis
Novel N-butyrylated hyaluronic acid analog treats rheumatoid arthritis through both anti-inflammatory and antioxidant mechanisms
Published: 24th May 2021

Patents
- US 9,644,050 “Hyaluronic Acid Derivatives”
- Japanese Patent JP6363119B2.
- Patent Applications filed in US, China and Canada for use in hyperuricemia and gouty arthritis
IP Status
- Patented
- Patent application submitted
Seeking
- Development partner
- Commercial partner
- Licensing
- Seeking investment